Patents Assigned to Snowden Pharmac uticals,LLC
  • Treatment of disorders secondary to organic impairments
    Publication number: 20040157934
    Abstract: A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is sibutramine.
    Type: Application
    Filed: December 31, 2003
    Publication date: August 12, 2004
    Applicant: Snowden Pharmac uticals,LLC
    Inventor: Peter Sterling Mueller